4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000899243-23-020075
See Remarks sold 4,066 shares at $1.35 ($5,489)
- See Remarks acquired 11,361 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ege David S. See Remarks | 2023-10-27 | Option exercise 10b5-1 | +11,361 | 71,057 | D: show line 1 in the form | ||
| Ege David S. See Remarks | 2023-10-30 | Sale 10b5-1 | −4,066 | $1.35 | $5,489 | 66,991 | D: show line 2 in the form |
| Open-market sales · 4,066 sh · avg $1.35 · $5,489 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ege David S. See Remarks | 2023-04-27 | Grant or award · Restricted Stock Units 10b5-1 | +22,721 | 22,721 | D: show line 3 in the form | ||
| Ege David S. See Remarks | 2023-10-27 | Option exercise · Restricted Stock Units 10b5-1 | −11,361 | 11,360 | D: show line 4 in the form |
Loading xslF345X05/doc4.xml…